INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holding Corporation - IART
PR Newswire
NEW YORK, Oct. 29, 2026
NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holding Corporation ("Integra" or the "Company") (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

The investigation concerns whether Integra and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On October 2, 2026, Integra pre-announced disappointing operational performance and cut its full-year 2026 revenue guidance range by $30.5 million at the midpoint. The Company revealed that severe flooding at its Cincinnati facility in July 2026 had caused widespread operational disruptions, impacting third-quarter revenues by roughly $7 million and creating an anticipated $15 million to $20 million headwind for the fourth quarter.
On this news, Integra's stock price fell $3.41 per share, or 21.2%, to close at $12.68 per share on October 2, 2026.
Then, on October 21, 2026, Integra released its finalized third-quarter 2026 financial results, confirming a revenue miss of $411.2 million against internal and analyst expectations. The Company admitted that the Cincinnati facility disruption was worse than originally anticipated and disclosed that execution pressure and competitive headwind constraints had driven an organic revenue contraction of 2.2% within its critical Tissue Reconstruction segment.
On this news, Integra's stock price fell $1.17 per share, or 8.76%, to close at $12.16 per share on October 21, 2026.
Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.
Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Danielle Peyton
Pomerantz LLP
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

The 10 Best Dividend Stocks

5 Stocks to Buy After Earnings

2 5-Star Stocks to Buy at Big Discounts

The Best Balanced Funds and ETFs

